Author(s): Charlotte Pawlyn, Faith Davies, David Cairns, et. al. Abstract: S 781 Session topic: 14. Myeloma and other monoclonal gammopathies – Clinical Background: Immunomodulatory agents are effective therapies for multiple myeloma (MM) acting via the modulation of cereblon. Lenalidomide (Len) has fewer side effects than Thalidomide (Thal), whilst retaining the benefits of...
Pro zobrazení tohoto obsahu je třeba být přihlášen.